CD8A and non-small cell lung carcinoma: MiRNA-34a is can suppress PDL-1 expression in colorectal cancer and NSCLC, thereby inducing CD8+ TILs (Li et al., 2016), so the miRNA/PDL-1 axis could be considered as a potential therapeutic and/or diagnostic biomarker.